Health Care: Drugs

Opexa Therapeutics Inc (OPXA: NASDAQ)

$1.04 0.0601 | 6.13%
10/22/14 - 03:59 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 1.27M 0.00 0.00 0.00
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 1.27M 0.00 0.00 0.00
Selling, General, and Administrative Expenses 3.67M 2.51M 2.41M 2.22M
Research & Development 9.18M 6.32M 3.34M 2.58M
Operating Income before D & A (EBITDA) -11.59M -8.83M -5.75M -4.80M
Depreciation & Amortization 2.07M 466.35K 210.25K 591.71K
Interest Income 14.98K 280.00 932.00 1.66K
Other Income - Net -2.48M 549.88K -9.69K -459.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -16.13M -8.74M -5.97M -5.39M
Interest Expense 2.27M 350.30K 3.14K 500.65K
Pre-Tax Income -18.39M -9.09M -5.97M -5.89M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -16.66M -8.93M -5.97M -5.47M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -16.66M -8.93M -5.97M -5.47M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -16.66M -8.93M -5.97M -5.47M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-16.66M -8.93M -5.97M -5.47M
Preferred Dividends
Net Income Available To Common -16.66M -8.93M -5.97M -5.47M
Basic EPS from Continuing Ops. -1.25 -1.54 -1.06 -1.28
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.25 -1.54 -1.06 -1.28
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.02 0.00
Basic EPS, Total -1.25 -1.54 -1.04 -1.28
Basic Normalized Net Income/Share -1.25 -1.54 -1.06 -1.28
EPS fr Continuing Ops. -1.25 -1.54 -1.06 -1.28
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.25 -1.54 -1.06 -1.28
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.02 0.00
EPS, Total -1.25 -1.54 -1.04 -1.28
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.25 -1.54 -1.06 -1.28
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with OPXA

Latest OPXA Headlines from TheStreet

More Financial News for OPXA

Press Releases for OPXA

See All Press Releases

Partner Headlines for OPXA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter